Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Experimental Gene Therapy Uses Brain Surgery to Achieve Results For Huntington’s Disease Patients, Part One
    source: pixabay.com

    Experimental Gene Therapy Uses Brain Surgery to Achieve Results For Huntington’s Disease Patients, Part One

    When we ‘do the math’ it adds up to the novel AMT-130 gene therapy receiving positive results from uniQure’s clinical trial investigating a small group (N=4) of individuals who were…

    Continue Reading Experimental Gene Therapy Uses Brain Surgery to Achieve Results For Huntington’s Disease Patients, Part One
    Female Police Detective Shares Near Death Experience from Immune Thrombocytopenia
    source: pixabay.com

    Female Police Detective Shares Near Death Experience from Immune Thrombocytopenia

      MSN recently carried the gripping story of how Elizabeth Finch, a Greeley Colorado police detective, spent last year fighting for her life due to complications from an autoimmune disease…

    Continue Reading Female Police Detective Shares Near Death Experience from Immune Thrombocytopenia
    Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers
    source: pixabay.com

    Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers

      Dr. Jung-Mo Ahn, associate professor at Dallas University in Texas, created a molecule that kills a broad range of treatment-resistant cancers. The newly targeted group includes triple-negative breast cancer.…

    Continue Reading Dallas University Researcher and Colleagues Create a Molecule That Kills a Wide Range of Treatment-Resistant Cancers
    The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy
    source: pixabay.com

    The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy

       Business Wire published an August 10th news release announcing that Cure Rare Disease, a non-profit based in Boston, Massachusetts received FDA approval to administer CRD-TMH-001 (CRD), its first-ever therapeutic.…

    Continue Reading The FDA Grants Approval to Begin Dosing First-in-Human CRISPR Technology to Treat Duchenne Muscular Dystrophy
    Myelodysplastic Syndromes: The FDA Grants Fast Track Designation for Eltanexor
    source: pixabay.com

    Myelodysplastic Syndromes: The FDA Grants Fast Track Designation for Eltanexor

      Karyopharm Therapeutics, a pharmaceutical company focusing on novel cancer therapies, has issued a statement via PR Newswire that the FDA has granted regulatory designations to eltanexor, Karyopharm’s Selective Inhibitor…

    Continue Reading Myelodysplastic Syndromes: The FDA Grants Fast Track Designation for Eltanexor

    FDA Approves Bylvay for Treatment of Progressive Familial Intrahepatic Cholestasis

      According to a recent press release from Globe Newswire, Albireo Pharma announced that Lancet Gastroenterology published results of the PEDFIC 1 trial evaluating Bylvay® in the treatment of progressive…

    Continue Reading FDA Approves Bylvay for Treatment of Progressive Familial Intrahepatic Cholestasis
    Seventeen Pediatric Patients Had Spontaneous Recovery From IgA Vasculitis-Associated Nephritis
    source: pixabay.com

    Seventeen Pediatric Patients Had Spontaneous Recovery From IgA Vasculitis-Associated Nephritis

      A recent article published in Physicians Weekly and also by the National Institute of Health stated that immunosuppressive medication and kidney biopsies may not be necessary if children with…

    Continue Reading Seventeen Pediatric Patients Had Spontaneous Recovery From IgA Vasculitis-Associated Nephritis

    Experimental CAR T-Cell Therapy for Relapsed/Refractory ALL Patients Receives FDA Designations

    Targeted Oncology recently published an article describing a group of T cell malignancies associated with blood disorders (hematologic cancers). Currently, a high rate of patient deaths and relapses are occurring…

    Continue Reading Experimental CAR T-Cell Therapy for Relapsed/Refractory ALL Patients Receives FDA Designations

    New Study Highlights a Protein With the Potential to Predict Cancer Deaths and Type 2 Diabetes Risk

    Inside Precision Medicine recently featured an article describing a study that was published in the European journal Diabetologia conducted by a team of Chinese and Swedish researchers. The study suggested…

    Continue Reading New Study Highlights a Protein With the Potential to Predict Cancer Deaths and Type 2 Diabetes Risk

    British Researchers Announce Positive Results from New Study of Potentially Curative Treatment for Hemophilia Patients

    According to a recent article in the British publication Latest Page News, doctors at the University College in London and Royal Free London believe that a ‘cure’ is possible within…

    Continue Reading British Researchers Announce Positive Results from New Study of Potentially Curative Treatment for Hemophilia Patients
    Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    source: pixabay.com

    Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

      Researchers acknowledge that the primary cause of failure of stem cell transplants is disease relapse. This holds true specifically for allogeneic hematopoietic stem cell transplants where a cancer patient…

    Continue Reading Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes